Arthur J. Moss American cardiologist
Moss, Arthur
VIAF ID: 315236100 (Personal)
Permalink: http://viaf.org/viaf/315236100
Preferred Forms
-
100 0 _
‡a
Arthur J. Moss
‡c
American cardiologist
-
100 1 _ ‡a Moss, Arthur
4xx's: Alternate Name Forms (3)
Works
| Title | Sources |
|---|---|
| Advances in managing heart failure and sudden cardiac death: synergies between devices and drugs : proceedings from the IX Pan-European Scientific Symposium May 30-31, 2003, in Paris, France |
|
| Characterization and predictors of first and subsequent inappropriate ICD therapy by heart rate ranges: Result of the MADIT-RIT efficacy analysis |
|
| Congenital long QT syndrome: considerations for primary care physicians |
|
| Cost-effectiveness of implanted defibrillators in young people with inherited cardiac arrhythmias. |
|
| Cumulative burden of atherosclerotic risk genotypes and the age at onset of a first myocardial infarction: a case-only carriership approach. |
|
| Effect of elapsed time from coronary revascularization to implantation of a cardioverter defibrillator on long-term survival in the MADIT-II trial |
|
| Effectiveness of cardiac resynchronization therapy by the frequency of revascularization procedures in ischemic cardiomyopathy patients |
|
| Effectiveness of high rate and delayed detection ICD programming by race: A MADIT-RIT substudy |
|
| Effects of implantable cardioverter/defibrillator shock and antitachycardia pacing on anxiety and quality of life: A MADIT-RIT substudy |
|
| Electrocardiographic identification of drug-induced QT prolongation: assessment by different recording and measurement methods. |
|
| Factors associated with ventricular inducibility in the MADIT-II study population |
|
| Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D |
|
| Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact |
|
| Inflammatory markers modify the risk of recurrent coronary events associated with apolipoprotein A-I in postinfarction patients |
|
| Left ventricular pacing threshold and outcome in MADIT-CRT |
|
| MADIT-II: clinical implications |
|
| Multicenter Automatic Defibrillator Implantation Trial-Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD): Design and clinical protocol |
|
| Novel compound heterozygous mutations in the KCNQ1 gene associated with autosomal recessive long QT syndrome (Jervell and Lange-Nielsen syndrome). |
|
| Polymorphism in the angiotensinogen gene, hypertension, and ethnic differences in the risk of recurrent coronary events |
|
| Polymorphisms in the paraoxonase and endothelial nitric oxide synthase genes and the risk of early-onset myocardial infarction |
|
| Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial |
|
| Prognostic significance of fragmented QRS complex for predicting the risk of recurrent cardiac events in patients with Q-wave myocardial infarction |
|
| Prognostic value of location and type of myocardial infarction in the setting of advanced left ventricular dysfunction |
|
| Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction |
|
| QRS fragmentation and the risk of sudden cardiac death in MADIT II |
|
| QT interval: how to measure it and what is "normal" |
|
| Reduction in inappropriate therapy and mortality through ICD programming |
|
| Reply: The Benefit of Cardiac Resynchronization Therapy Is Not Hindered by the Number of Comorbidities. |
|
| Repolarization duration in patients with conduction disturbances after myocardial infarction |
|
| Risk Stratification of Type 2 Long-QT Syndrome Mutation Carriers With Normal QTc Interval: The Value of Sex, T-Wave Morphology, and Mutation Type |
|
| Risk stratification using heart rate turbulence and ventricular arrhythmia in MADIT II: usefulness and limitations of a 10-minute holter recording. |
|
| Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome |
|
| Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial. |
|
| Sex Differences in Inappropriate ICD Device Therapies: MADIT-II and MADIT-CRT. |
|
| Shlomo Stern (1928-2013) - visionary leader with great legacy in memoriam. |
|
| Thrombospondin-4 polymorphism (A387P) predicts cardiovascular risk in postinfarction patients with high HDL cholesterol and C-reactive protein levels |
|
| Time-dependent risk of Fidelis lead failure |
|
| Time-dependent risk reduction of ventricular tachyarrhythmias in cardiac resynchronization therapy patients: a MADIT-RIT sub-study |
|
| Usefulness of standard electrocardiographic parameters for predicting cardiac events after acute myocardial infarction during modern treatment era |
|
| Validation of an automatic diagnosis of strict left bundle branch block criteria using 12-lead electrocardiograms. |
|
| Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy. |
|
| Ventricular Electrical Delay Measured From Body Surface ECGs Is Associated With Cardiac Resynchronization Therapy Response in Left Bundle Branch Block Patients From the MADIT-CRT Trial (Multicenter Automatic Defibrillator Implantation-Cardiac Resync |
|
| Web-based virtual cardiac symposia: a new approach for worldwide professional medical education. |
|
